Cargando…

PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease

BACKGROUND & AIMS: Fibroblast activity is a key feature of fibrosis progression and organ function loss, leading to liver-related complications and mortality. The fibrogenesis marker, PRO-C3, has been shown to have prognostic significance in relation to fibrosis progression and as a treatment ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Mette J., Dolman, Grace E., Harris, Rebecca, Frederiksen, Peder, Chalmers, Jane, Grove, Jane I., Irving, William L., Karsdal, Morten A., Patel, Keyur, Leeming, Diana Julie, Guha, Indra Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240276/ https://www.ncbi.nlm.nih.gov/pubmed/37284140 http://dx.doi.org/10.1016/j.jhepr.2023.100743

Ejemplares similares

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
por: Erhardtsen, Elisabeth, et al.
Publicado: (2021)

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)

Biomarkers of Type IV Collagen Turnover Reflect Disease Activity in Patients with Early-Stage Non-Alcoholic Fatty Liver (NAFL)
por: Lønsmann, Ida, et al.
Publicado: (2023)

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma
por: Leeming, Diana Julie, et al.
Publicado: (2020)

Health related quality of life in individuals at high risk of chronic liver disease: Impact of a community diagnostic pathway
por: Zoe, Tildesley, et al.
Publicado: (2020)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
por: Jensen, Christina, et al.
Publicado: (2020)

Quantification of extracellular matrix remodeling for the non-invasive identification of graft fibrosis after liver transplantation
por: Engel, Bastian, et al.
Publicado: (2023)

Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders()()
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD
por: Cohen, Catherine C., et al.
Publicado: (2021)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
por: Schierwagen, Robert, et al.
Publicado: (2013)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
por: Nielsen, Mette J., et al.
Publicado: (2015)

An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution
por: Pehrsson, Martin, et al.
Publicado: (2022)

Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption - implications for osteoclast quality
por: Neutzsky-Wulff, Anita V, et al.
Publicado: (2010)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis
por: Genovese, Federica, et al.
Publicado: (2014)

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community
por: Chalmers, Jane, et al.
Publicado: (2019)

Endotrophin is associated with chronic multimorbidity and all-cause mortality in a cohort of elderly women
por: Staunstrup, Line Mærsk, et al.
Publicado: (2021)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
por: Kendall, Timothy J, et al.
Publicado: (2018)

The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
por: Genovese, Federica, et al.
Publicado: (2014)

Association of Systemic Collagen Type IV Formation with Survival among Patients Undergoing Hemodialysis
por: Leeming, Diana J., et al.
Publicado: (2013)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?
por: Leeming, Diana J, et al.
Publicado: (2008)

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
por: Leeming, Diana J., et al.
Publicado: (2012)

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
por: Vesterhus, Mette, et al.
Publicado: (2020)

Relevance of Biomarkers in Serum vs. Synovial Fluid in Patients with Knee Osteoarthritis
por: Kalogera, Stefania, et al.
Publicado: (2023)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer
por: Willumsen, Nicholas, et al.
Publicado: (2017)

Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor
por: Hansen, Niels Ulrik Brandt, et al.
Publicado: (2016)

Markers of Basement Membrane Remodeling Are Associated With Higher Mortality in Patients With Known Atherosclerosis
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

Reliable computational quantification of liver fibrosis is compromised by inherent staining variation
por: Astbury, Stuart, et al.
Publicado: (2021)

Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease
por: Karsdal, Morten A., et al.
Publicado: (2023)

PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension
por: Jansen, Christian, et al.
Publicado: (2014)

Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis
por: Innes, Hamish, et al.
Publicado: (2022)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_93r501nivbat96sqn9nf1tjq90